| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/08/2006 | US7087625 N-substituted aniline and diphenylamine analogs |
| 08/08/2006 | US7087615 Antiinflammatory agents; antiarthritic agents |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087612 Amine oxidase inhibitor; therapy for Alzheimer's diseases, Parkinson's disease |
| 08/08/2006 | US7087607 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087601 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087596 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 08/08/2006 | US7087594 Alkyl ether derivatives or salts thereof |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | US7087590 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 08/08/2006 | US7087587 Blending with adjuvants, compression, coating |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087400 Using a 11 beta-reductase inhibitor in the manufacture of a medicament for control of 11-keto steroid conversion to 11 beta-hydroxysteroid in vivo |
| 08/08/2006 | US7087399 Purification; analyzing; drug screening; Alzheimer's diseases; central nervous system disorders |
| 08/08/2006 | US7087252 For therapy of senile dementia, and inhibition of aggregation of blood platelets |
| 08/08/2006 | US7087241 Administering a transmucosal formulation, comprising oxybutynin to a subject to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1, wherein the transmucosal formulation optionally includes a permeation enhancer |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/08/2006 | CA2240571C The use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 08/08/2006 | CA2207258C Xanthine compounds having terminally aminated alkynol side chains |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/03/2006 | WO2006081431A2 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | WO2006081252A2 Use of 1-benzyl-1-hydr0xy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds as analgesics |
| 08/03/2006 | WO2006081171A1 Humanized anti-amyloid antibody |
| 08/03/2006 | WO2006081170A1 Nutritional supplement containing honey |
| 08/03/2006 | WO2006081072A1 Antagonists of the mglu receptor and uses thereof |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080555A1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080477A1 Norvaline derivative and method for preparation thereof |
| 08/03/2006 | WO2006080439A1 Tricyclic compound |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2006080287A1 2-azolylimino-1,3-thiazine derivative |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006080086A1 Composition for recovery from or prevention of central nervous system fatigue |
| 08/03/2006 | WO2006080043A2 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 08/03/2006 | WO2006079811A1 Reducing drug dependence or addiction |
| 08/03/2006 | WO2006079731A2 Use of cacao polyphenols for treating a prostate hyperplasia, a specific cacao extract and applications |
| 08/03/2006 | WO2006079637A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/03/2006 | WO2006079548A1 Organic compounds |
| 08/03/2006 | WO2006079547A2 Spm 927 for add-on therapy of schizophrenia |
| 08/03/2006 | WO2006079476A1 Phantom phenomena treatment |
| 08/03/2006 | WO2006063247A3 Regulated expression of transgenes in the central nervous system of mammals |
| 08/03/2006 | WO2006061136A3 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer’s disease |
| 08/03/2006 | WO2006050472A3 Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids |
| 08/03/2006 | WO2006050007A3 Substituted indolizines and derivatives as cns agents |
| 08/03/2006 | WO2006044421A3 Cardiac safe, rapid medication delivery |
| 08/03/2006 | WO2006035237A3 Methods and compositions relating to alzheimer's disease |
| 08/03/2006 | WO2006032432A3 Donepezyl salts |
| 08/03/2006 | WO2005103715A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 08/03/2006 | WO2005046659A3 Migraine treatments including isovaleramide compounds and serotonin agonists |
| 08/03/2006 | US20060173178 Reducing 2-nitro-2'-carboxy-diphenylsulfide derivative in presence of hydrogen gas and reduction catalyst; subjecting 2-amino-2'-carboxy-diphenylsulfide derivative to dehydration-condensation to produce dibenzo[b,f][1,4]thiazepin-11-one compound |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173054 Treating Alzheimer's disease; e.g. 2',3',4',5,5',6,7,8,9,10-Decahydro-2-(5-(4-fluorophenyl)-1-methyl-pyrazol-3-yl)-5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-(1,2,5)thiadiazole)-1',1'-dioxide |
| 08/03/2006 | US20060173047 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173036 4-{[3-(3-aminopropyl)-5-(diisobutylamino)-3H-imidazo[4,5-b]pyridin-2-yl]amino}-N-methylbenzamide hydrochloride; melanocortin receptors MC4 modulator; analgesic agent; neuropatic pain; antidepressant, anxiolytic agent; obesity |
| 08/03/2006 | US20060173035 3-Aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173031 Therapeutic agent for schizophrenia |
| 08/03/2006 | US20060173016 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; treatment of cancer; additional anticancer drug or radiotherapy. |
| 08/03/2006 | US20060173014 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(3-nitrophenyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172999 2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-phenyl-tetrahydropyran-4-yl]methyl-2-oxa-8-aza-spiro[4,5]decan-4-ol; neurokinin 1 (NK-1) receptor antagonists; antidepressant, anxiolytic, analgesic, antiinflammatory agent; migraine, emesis or postherpetic neuralgia |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | US20060172946 Having serine protease inhibitory activity |
| 08/03/2006 | US20060172930 Apoptosis-inducing gene and utilization of the same |
| 08/03/2006 | US20060172391 BMP-11 compositions |
| 08/03/2006 | US20060172360 Mkk7 activation inhibitor |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172337 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 08/03/2006 | US20060172297 Enhancers specific to motor nerve cells/sensory nerve cells |
| 08/03/2006 | US20060172006 Sustained-release tramadol formulations with 24-hour clinical efficacy |
| 08/03/2006 | US20060171928 Monocyte-origin multipotent cell momc |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2596144A1 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | CA2595994A1 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation |
| 08/03/2006 | CA2595898A1 Method and composition for treating central nervous system disorders |
| 08/03/2006 | CA2595519A1 Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 08/03/2006 | CA2595334A1 Polymorphic forms of aripiprazole and processes for making |
| 08/03/2006 | CA2595330A1 Spm 927 for add-on therapy of schizophrenia |
| 08/03/2006 | CA2595170A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/03/2006 | CA2594721A1 Process for producing (z)-1-phenyl-1-(n,n-diethylaminocarbonyl)-2-phthalimidomethylcyclopropane |
| 08/03/2006 | CA2589860A1 Humanized anti-amyloid antibody |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1686127A1 New heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases |
| 08/02/2006 | EP1686117A1 Polymorph and solvates of aripiprazole |
| 08/02/2006 | EP1685847A1 Beta-amyloid-analogue-T-cell epitop vaccine |
| 08/02/2006 | EP1685840A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 08/02/2006 | EP1685839A1 Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist |
| 08/02/2006 | EP1685838A1 Compounds for the treatment of addictive disorders |
| 08/02/2006 | EP1685833A1 Remedy for diabetes |